#hivscreening

Early HIV detection plays a critical role in addressing the rising HIV infection rates in the Philippines, especially among key populations and youth aged 15–24. Timely screening helps reduce public health risks, enables faster linkage to antiretroviral therapy (ART), and prevents long-term health complications.

The iCARE HIV 1&2 Rapid Screen Test offers a reliable and efficient solution for early diagnosis. With accurate antibody detection and results available in just 20 minutes, it supports healthcare professionals in closing treatment gaps and improving patient outcomes through early intervention.

Early screening empowers individuals, strengthens public health responses, and supports better HIV management across communities.

With the iCare HIV 1&2 4th GEN Home Test Kit, quick, accurate HIV testing is at your fingertips. This compact, confidential kit allows individuals to take charge of their health and make informed decisions, strengthening global diagnostic care with every test.

Jal Medical’s iCare Rapid Anti-HIV (1&2) Test is a game-changer in HIV screening, offering fast, reliable, and easy-to-use detection. Designed for both medical professionals and individuals, this test works with whole blood, serum, or plasma, ensuring versatility in diverse settings. Stay ahead in the fight against HIV with early detection and proactive care.

Jal Medical is proud to be at the forefront of healthcare innovation with the iCARE HIV 1&2 Rapid Screen Test. This highly reliable and quick test offers healthcare professionals a trusted tool for initial HIV screening. With results in just 20 minutes, it ensures efficient and accurate detection of antibodies to HIV in human blood, serum, or plasma.

HIV is a virus that destroys the body’s immune system, making the body unable to fight against illnesses, infections, and diseases. It has been discovered that more men are living with HIV than women. An estimate has been made, showing 80% of the people living with HIV are men.